{"id":1041624,"date":"2024-07-15T02:35:37","date_gmt":"2024-07-15T06:35:37","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/myriad-genetics-and-personalis-cross-license-foundational-mrd-intellectual-property-to-broaden-patient-access-to-testing\/"},"modified":"2024-08-17T16:50:35","modified_gmt":"2024-08-17T20:50:35","slug":"myriad-genetics-and-personalis-cross-license-foundational-mrd-intellectual-property-to-broaden-patient-access-to-testing","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/myriad-genetics-and-personalis-cross-license-foundational-mrd-intellectual-property-to-broaden-patient-access-to-testing.php","title":{"rendered":"Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing"},"content":{"rendered":"<p><![CDATA[SALT LAKE CITY and FREMONT, Calif., July  11, 2024  (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq: MYGN), a leader in genetic testing and precision medicine, and Personalis, Inc. (Nasdaq: PSNL) today announced that they have entered into an agreement to cross-license patent estates covering tumor-informed approaches to detect minimal residual disease (MRD). The agreement helps solidify each company\u2019s freedom to operate in the MRD market and broadens patient access to the benefits of MRD testing.]]><\/p>\n<p>See original here:<br \/>\n<a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/07\/11\/2911844\/0\/en\/Myriad-Genetics-and-Personalis-Cross-License-Foundational-MRD-Intellectual-Property-to-Broaden-Patient-Access-to-Testing.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing\" rel=\"noopener\">Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See original here: Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/myriad-genetics-and-personalis-cross-license-foundational-mrd-intellectual-property-to-broaden-patient-access-to-testing.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[36],"tags":[],"class_list":["post-1041624","post","type-post","status-publish","format-standard","hentry","category-medical-school"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1041624"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1041624"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1041624\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1041624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1041624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1041624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}